Hjem › Kronisk inflammatorisk demyeliniserende polyradikuloneuropati › North Carolina
Kronisk inflammatorisk demyeliniserende polyradikuloneuropati kliniske forsøg i North Carolina
6 studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati søger deltagere på steder i North Carolina.
Officiel studietekst (engelsk)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1635, Chapel Hill
- Site Number - 1610, Charlotte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- The Neurological Institute, PA, Charlotte
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Raleigh Neurology Associates- Site Number : 8400043, Raleigh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06290141Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- PPD Virtual, Wilmington
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07264426A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of North Carolina (UNC), Chapel Hill
- Duke University Hospital, Durham
- Raleigh Neurology Associates, Raleigh
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Wake Forest University - School of Medicine - Central, Winston-Salem
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 21. nov. 2025 · NCT06538064Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.